mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.009 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.009 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.01 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.01 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.01 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.01 |
mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |